Results 161 to 170 of about 2,223 (207)

JAK Inhibitors for Treatment of VEXAS Syndrome: A Systematic Review of 186 Cases. [PDF]

Dermatol Res Pract
Bahramian S, Fazeli P, Rafati A, Demokri S, Memari H, Soheili A, Esmaeili F, Pourmehdi Ardebili M, Erfani H, Vahabi SM.   +9 more
europepmc   +1 more source

Is immunotherapy safe and effective in patients with VEXAS syndrome? [PDF]

J Immunother Cancer
Marvisi C, Muratore F, Cusenza VY, Nicoli D, Farnetti E, Bonanno O, Spaggiari L, Banzi M, Longo C, Salvarani C.   +9 more
europepmc   +1 more source

VEXAS syndrome: cutaneous manifestations and UBA1 gene variants in the diagnosis of a rare autoinflammatory syndrome - Case report. [PDF]

An Bras Dermatol
Crivelatti I, Souza SM, Dimatos OC, Funchal GDG, Soares AM, Pereira AA.   +5 more
europepmc   +1 more source

Sobre dos nuevos géneros de Calleidini (Col. Carabidae) procedentes de Chile, Apterodromites nov. y Falsodromius nov. [PDF]

Mateu, J.
core  

Exploring patient-reported outcomes and morbidity burden of patients with VEXAS syndrome: a scoping review. [PDF]

EClinicalMedicine
Efficace F, Krepper D, Sparano F, Fazi P, Voso MT, Gurnari C.   +5 more
europepmc   +1 more source

VEXAS: A review of current understandings and emerging treatment strategies. [PDF]

Front Immunol
Holden R, Jeelal Y, McLean-Tooke A, Pathmanathan K, Nolan D.   +4 more
europepmc   +1 more source

Reframing-renaming(?)-myelodysplastic syndromes/neoplasms and clonal hematopoiesis of indeterminate potential. [PDF]

Leukemia
Lee NC, Miao R, Young NS.
europepmc   +1 more source

Los primeros terebratúlidos (Braquiópodos) del Devónico de la Cordillera Cantábrica (N de España) [PDF]

García-Alcalde Fernández, Jenaro Luis
core  

VEXAS syndrome in a woman

Rheumatology, 2021
International ...
Thomas Barba, Pierre Sujobert
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Thrombotic manifestations of VEXAS syndrome

Seminars in Hematology, 2021
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently described autoinflammatory syndrome characterized by diffuse inflammatory manifestations, predisposition to hematological malignancy, and an association with a high rate of thrombosis.
Emma M Groarke, Yogendra Kanthi
exaly   +3 more sources